Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
Innovation Pharmaceuticals Inc (IPIX) Message Board
Search
Search Type
Board
Post
Member
Hide Board Information
Show Board Information
Innovation Pharmaceuticals Inc IPIX
Board Mod:
Dynabolic
Asst Mods:
Kelt
Drano
NotRichYet2
Loose Lips
someconcerns
Mo
Last Post: 06/23/2025 3:20:56 PM
Board Marks: 278
Posts Today: 0
Board Views Today: 5340
Innovation Pharmaceuticals Inc. (IPIX)
Company Website:
http://www.ipharminc.com/
IPIX Stock Message Board Intro
Innovation Pharmaceuticals Inc (OTCMRKTS: IPIX) Stock Message Board
IPIX Company Profile
IPIX Time & Sales
IPIX Recent News
IPIX Filings
IPIX Financials
IPIX Buy Rating
Create New Post
View All Posts
Board Mark
Banned
Post
Subject
Author
Posted On
64595
Yesterdays PR was terrific. Brilacidin was found
(15)
farrell
05/20/2020 8:55:40 PM
70679
IPIX .. NR (non retail) would normally be showing
(16)
4kids
10/28/2021 12:32:05 PM
72046
Innovation Pharmaceuticals Announces Publication
(7)
Mo
10/04/2022 12:13:17 PM
72181
WAKEFIELD, MA / January 4, 2023 BT
(7)
Drano
01/09/2023 8:51:41 AM
69577
They are a well paid tool of the shorts. Go
(3)
AlanC
05/18/2021 8:30:53 AM
69576
Cydy reply...
(2)
Patchesohoulihan
05/18/2021 6:52:03 AM
69575
Nice work Major Pete. All relevant and pertinent.
(2)
scgmck1
05/17/2021 8:16:47 PM
69574
CYDY serves a different need than Brilacidin.
(8)
Drano
05/17/2021 5:07:02 PM
69573
Wrong. This is filled with innuendo and
(10)
Drano
05/17/2021 5:01:32 PM
69572
FDA: Statement on Leronlimab. Another COVID-19
(2)
crashco
05/17/2021 4:52:28 PM
69571
Rosen Law Firm, that is. Got a sticky N on my
Drano
05/17/2021 11:53:57 AM
69570
Remember the Rose Law Firm that tried to
(8)
Drano
05/17/2021 10:58:41 AM
69569
The SEC needs to be fired!D
(6)
AlanC
05/17/2021 8:34:36 AM
69567
This is not a coincidence. Let's not also
(3)
Fit007
05/15/2021 9:53:22 AM
69566
The patient enrollment portion of the trial seems
(9)
petemantx
05/14/2021 3:04:16 PM
69564
Absolutely!!! I work in three different ERs and
(2)
DrTim
05/13/2021 7:01:03 PM
69563
Make that 8 Yankees now. Fully vaccinated and he
(1)
bettingbig
05/13/2021 6:17:58 PM
69562
This new CDC guidance is a catastrophe. Even if a
(7)
Drano
05/13/2021 5:39:05 PM
69561
Fog of War. The answers will be decades
crashco
05/13/2021 5:21:55 PM
69560
Crashco let's see what the numbers say when the
(1)
bettingbig
05/13/2021 5:15:11 PM
69559
Slightly dated search results. Vaccinated but
crashco
05/13/2021 5:08:22 PM
69558
In that a third of the U.S. is now fully
NotRichYet2
05/13/2021 4:36:43 PM
69556
There remains an awful lot of groping for
(5)
crashco
05/13/2021 2:44:41 PM
69555
Wait!!! How can this be? After all, BL has told
DrTim
05/13/2021 2:24:17 PM
69552
It may take 138 (as reported by Russian State
(5)
crashco
05/13/2021 10:06:23 AM
69550
At this rate we should be done recruiting
bettingbig
05/13/2021 9:49:40 AM
69549
"Alfasigma S.p.A. (Alfasigma)the
(12)
Drano
05/13/2021 9:35:14 AM
69548
New Innovation Pharmaceuticals Press Release.
(7)
crashco
05/13/2021 8:15:43 AM
69547
Something to consider- The gorilla dust crowd
(1)
bandg
05/12/2021 6:30:01 PM
69546
Wonder if FCCDC will look in to this for
(1)
bettingbig
05/12/2021 4:42:45 PM
69545
On another board, they refer to that drug as
(2)
Drano
05/12/2021 3:31:32 PM
69544
For those who also read IHUB, you have read posts
(13)
falcon74
05/12/2021 1:46:57 PM
69541
The MIAI (Multi-Identity Activity Index) has been
(7)
Drano
05/12/2021 1:20:15 PM
69540
Thanks for sharing. the swamp seems especially
(5)
Chemdeps
05/12/2021 12:09:19 PM
69539
Stink bid filled @ .1784. Thanks again shorty.
(5)
scgmck1
05/12/2021 11:31:27 AM
69537
10-q filed this week and we will get trial
(8)
bettingbig
05/12/2021 9:48:41 AM
69535
Z looks like we are staying with 11 sites with a
(6)
bettingbig
05/12/2021 9:19:44 AM
69534
I love the 54 share trade at .17, what a joke.
(2)
zdubble17
05/12/2021 9:11:54 AM
69529
Here's a link to the COVID board at the Hangout.
(1)
Drano
05/11/2021 3:12:01 PM
69526
Whomever posts a link without a brief description
Kelt
05/11/2021 1:28:42 PM
69520
Well said Farrell. Thats the Cliff Notes
(5)
scgmck1
05/11/2021 11:39:39 AM
69518
Excellent logic. Makes you wonder what might also
(2)
bandg
05/10/2021 9:56:37 PM
69517
Great review. Anyone looking for a detailed
(15)
farrell
05/10/2021 6:58:03 PM
69516
I guess this is one way to show LOW covid daily
bettingbig
05/10/2021 6:33:28 PM
69513
Antivirals, ideally Brilacidin, will be required
(3)
crashco
05/08/2021 4:20:28 PM
69511
A successful conclusion to the current B-CV19
(22)
Mo
05/07/2021 11:42:45 PM
69510
Attached link bodes well for getting non-dilutive
(3)
petemantx
05/07/2021 8:52:11 PM
69506
And I bet the EMA is going to call YOU for YOU to
(2)
bandg
05/07/2021 9:53:41 AM
69505
I'm something alright. Best of luck with your
(2)
crashco
05/07/2021 9:51:20 AM
69503
Wow...thanks for interpreting the program for me
Chemdeps
05/07/2021 8:49:53 AM
69502
As written the program describes goals to be
(5)
crashco
05/07/2021 7:03:35 AM
69501
So the announcement by the European Commission
Chemdeps
05/07/2021 6:38:04 AM
69500
EUA may be granted to any drug following a
(2)
crashco
05/07/2021 6:36:15 AM
69499
So no emergency use authorization for any
Chemdeps
05/07/2021 6:25:37 AM
Newer
Older
Recent Articles
Spacruzzi Hot Tub Boats: A Game-Changer in Rentals
Celoxfi Revolutionizes Crypto Security with Full Asset Coverage
Maui Land & Pineapple Company: Strong Results Thrive
CMB.TECH Announces Key Exemption Document for Merger Plans
COSCIENS Biopharma Updates on Financial Results and Strategy
Enthusiast Gaming's Financial Landscape: Q2 2025 Analysis
Veea Inc. Completes $9.2 Million Stock Offering for Growth
Emerita Resources Launches New Concurrent Offering for Growth
BioSyent's Upcoming Earnings Release and Business Insights
Exploring Innovations in IPF Treatment at the IPF Summit 2025
Hesai Group Showcases Remarkable Growth in Q2 2025
Flexible Solutions International Reports Strong Q2 2025 Results
Navient Approves Exciting Third Quarter Dividend for Shareholders
Millicom Forms Strategic Partnership to Enhance Colombian Market
Teladoc Health Expands Virtual Care with Telecare Acquisition
Neogen Corporation Investors: Participation in Fraud Investigation
Elemental Altus Royalties Plans for Q2 Results Announcement
Daily Journal Corporation Reports Significant Revenue Growth
Snowline Gold Corp. Secures $80 Million for Growth Initiatives
G Mining Ventures Achieves Record Growth and Revenue in Q2
Appili Therapeutics Shares Key Updates in Financial Report
Enthusiast Gaming's Second Quarter Insights and Highlights
Orca Energy Group Inc. Reports Strong Q2 2025 Financials
Hesai Group Delivers Impressive Financial Growth for Q2 2025
Mill City Ventures Unveils Innovative Treasury Strategy Growth
Maxeon Solar Technologies Reports Financial Insights for 2025
INX Digital's Q2 2025 Performance Shows Strategic Growth
East Side Games Group Achieves Growth with New Launches
Maui Land & Pineapple Co Reports Impressive Growth in Q2 2025
Appili Therapeutics' Promising Progress in Infectious Disease Sector
Orca Energy Group's Q2 2025 Report: Growth and Challenges
Mill City Ventures Achieves Growth and Launches SUI Strategy
Nutex Health's Stock Repurchase Program and Financial Insights
Hesai Technology Partners with Toyota for Advanced Lidar Systems
Maxeon Solar Technologies Unveils Financial Results for 2025
Scripps News Celebrates Five National Murrow Awards Victories
Watercrest Senior Living Expands Management with Sage Park Launch
Exciting Merger News: Regional Health Properties and SunLink Unite
Flagship Communities REIT Expands with New Kentucky Acquisition
Invivyd Targets Rapid FDA Approval for Novel COVID-19 Antibody
Invivyd Achieves New Milestones with Impressive Financials
Inhibikase Therapeutics: Financial Growth and Future Prospects
Range Impact Reports Positive Growth in Recent Financial Results
XTI Aerospace's Strong Advances in TriFan 600 Development
Invivyd Inc. Shares Impressive Growth Amid Regulatory Advances
Inhibikase Therapeutics Updates: Q2 2025 Financial Overview
Celebrating Innovators: 2025 MAXX Awards Bestowed Honors
Root, Inc. to Engage Investors Through Key Conferences
Understanding the Grave Consequences of False Allegations
Investors Take Notice: Sable Offshore Corp. Faces Lawsuit